MV Capital Management’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding RPRX
MV Capital Management's RPRX Position: Q2 2026 in Review
MV Capital Management increased its Royalty Pharma (RPRX) stake by 18% in Q2 2026, buying an estimated $989 and bringing the position to 124 shares worth $6.95K. The position accounts for ﹤0.01% of the portfolio, ranked #593.
MV Capital Management first reported a position in RPRX in Q4 2023 and has held it in 11 quarters since. 646 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.
- MV Capital Management held 124 shares of Royalty Pharma worth $6.95K as of Q2 2026.
- MV Capital Management bought 19 Royalty Pharma shares in Q2 2026, an estimated $989.
- Royalty Pharma made up ﹤0.01% of MV Capital Management's portfolio in Q2 2026, its #593 holding.
- MV Capital Management first reported a position in Royalty Pharma in Q4 2023 and has held it in 11 quarters since.
- 646 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.
Based on MV Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.